A5001339848- Chronic Kidney Disease and Diabetes
- Renal and Vascular Pathologies
- Angiogenesis and VEGF in Cancer
- Renal Diseases and Glomerulopathies
- Lymphatic System and Diseases
- Blood properties and coagulation
- Cardiovascular Issues in Pregnancy
- Renal and related cancers
- Renin-Angiotensin System Studies
- Retinal and Optic Conditions
- Diagnosis and Treatment of Venous Diseases
- Nitric Oxide and Endothelin Effects
- Retinal Diseases and Treatments
Inserm
2008-2013
Sorbonne Université
2008-2012
Hôpital Tenon
2011
Assistance Publique – Hôpitaux de Paris
2011
Hôpital Foch
2011
Abstract Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is accumulated in plasma during chronic kidney disease (CKD). It considered independent mortality and cardiovascular risk factor CKD patients. To test the involvement of ADMA progression, we investigated effects administration on renal structure compared these with $N^{\rm{G}}$ ‐nitro‐ L ‐arginine methyl ester (L‐NAME) treatment, a widely used exogenous inhibitor NOS that induces CKD. Three...